How new price transparency rules affect hospital prices
Official title: Effects of Negotiated Price Transparency Regulations: Evidence from Hospital Prices
Funded at Duke University · NIH-10733271 · Data updated 2026-11-12
This study looks at how new rules that make hospitals share their prices with insurance companies affect how much you pay for healthcare and the choices you have, helping us understand if being able to see prices makes care more affordable or if it might actually raise costs.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project start | August 1, 2023 |
| Project end | December 31, 2025 |
| Funding year | 2023 |
| Award (this year) | $42,886 |
| NIH project number | 1R36HS029269-01A1 |
| Project ID | NIH-10733271 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients with private health insurance who are affected by hospital pricing and transparency regulations.
✕Less likely to help
Patients who are uninsured or rely on government insurance programs may not benefit directly from this research.
What this research studies
This research investigates the impact of recent regulations requiring hospitals to publicly disclose their negotiated prices with insurers. By analyzing the effects of these transparency rules, the study aims to understand how they influence healthcare affordability and patient choices. The research will explore whether increased price visibility leads to lower costs for patients or if it inadvertently results in higher prices due to market dynamics. The findings could provide valuable insights into the relationship between price transparency and healthcare spending.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare affordability and better-informed patient choices.
How similar studies have gone: While the effects of price transparency in healthcare have been discussed, this specific approach to studying its impact is relatively novel and has not been rigorously tested.
Where this research is happening
-
Duke University
Durham, United States Active
Researchers
- Principal investigator: Behrer, Christopher — Duke University
- Study coordinator: Behrer, Christopher
Related research
Other NIH-funded projects on the same topics.
-
Investigating genetic factors in Lewy body diseases
This study is looking at how changes in a specific gene might play a role in conditions like Parkinson's disease and dementia, so that people can better understand how their genetics affect their health and possibly find more tailored treatments.
-
Targeting the PAX3-FOXO1 protein in a deadly childhood cancer
This study is looking at a specific protein that helps a tough childhood cancer called alveolar rhabdomyosarcoma, with the goal of finding new ways to treat kids who have this illness.
-
Improving population health by studying reproduction and development
This study is looking at how different things in our environment can impact pregnancy and the health of babies, and it’s for people who are planning to have children or are already parents, as it aims to help improve understanding and outcomes for everyone involved.
-
Modeling axon degeneration in C. elegans to help ALS patients
Researchers are using a tiny worm model to uncover how axons break down, which could point to new ways to help people with ALS and related nerve diseases.
-
Induced Suppression of Platelet Activity in Aneurysmal SAH Management
A new approach tests whether carefully reducing platelet activity can improve outcomes after aneurysmal subarachnoid hemorrhage.
-
AI-enhanced virtual reality tool to support remote emergency brain surgery training in Tanzania
A new AI-powered virtual reality tool helps non-experts in low-resource areas get real-time remote guidance for emergency traumatic brain injury surgery.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.